Video 21 Jun 2021 Orthocell (ASX:OCC) demonstrates potential to return function to paralysed limbs Orthocell has been featured in The Market Herald, following the announcement of clinical data from the CelGro nerve regeneration trial… Orthocell
Media, Video 27 May 2021 Video | Proactive Investors – May 2021 Orthocell CEO and Managing Director Paul Anderson speaks to Proactive following the announcement newly granted patents for its CelGro™ collagen… Orthocell
Video 06 Jan 2021 Australia’s TGA approves Orthocell’s Celgro™ regenerative collagen medical device Orthocell CEO Paul Anderson spoke to BioWorld, following marketing clearance from Australia’s Therapeutic Goods Administration (TGA) for our Celgro™ collagen… Orthocell
Video 10 Nov 2020 HCP Webinar | Latest Developments in the Biological Treatment of Cartilage – Professor Martin Sullivan Professor Martin Sullivan Foot and Ankle Surgeon at St. Vincent’s Clinic & North Shore Private Hospital in Sydney presents 'An… Orthocell
Media, Video 22 Sep 2020 Video | Proactive Investors Interview – September 2020 Orthocell CEO and Managing Director Paul Anderson spoke with Andrew Scott from Proactive Investors about the company being in an… Orthocell
Video 22 May 2020 Australia’s Orthocell submits 510(k) for Celgro™ regenerative collagen medical device Orthocell has been featured in BioWorld, following the submission of a 510(k) application to the U.S. FDA for our Celgro™… Orthocell
Video 11 Mar 2020 Orthocell looks to enter US market following positive CelGro™ study results Small Caps has featured Orthocell's plans to enter the US market following the success of our Celgro™ dental implant study. Orthocell
Video 16 Oct 2019 Australia’s Orthocell ready to file on interim Celgro™ data BioWorld has reported on Orthocell's plans to seek early FDA approval for our Celgro™ nerve regeneration treatment, following positive interim… Orthocell
Video 08 May 2019 Orthocell unveils first clinical trial results for nerve regeneration platform CelGro Early results from Orthocell's nerve regeneration study have been featured in Small Caps. Read the article HERE. Orthocell
Video 13 Feb 2019 Orthocell hails high success rate for tendon injury treatment Small Caps has featured the results from Orthocell's recent study that shows an 82% success rate using its novel stem… Orthocell
